| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/19/2004 | WO2002083866A3 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions |
| 02/19/2004 | WO2002081622A3 Plants characterized by enhanced growth and methods and nucleic acid constructs useful for generating same |
| 02/19/2004 | WO2002081496A3 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours |
| 02/19/2004 | WO2002078613A3 Immunoglobulin construct containing anti-mucin variable domain sequences for eliciting an anti-idiotype anti-tumor response |
| 02/19/2004 | WO2002077206A9 Compositiona and methods useful for hcv infection |
| 02/19/2004 | WO2002076380A3 Cytotoxic factors for modulating cell death |
| 02/19/2004 | WO2002074251A3 Monoclonal antibody therapy for pancreas cancer |
| 02/19/2004 | WO2002070750A3 Method of determining dihydropyrimidine dehydrogenase gene expression |
| 02/19/2004 | WO2002067663A8 Methods for effectuating mrna-mediated transfer of genetic information into plants and products of the same |
| 02/19/2004 | WO2002066616A3 Engineering fungi for the utilisation of l-arabinose |
| 02/19/2004 | WO2002063298A3 Gap junction permeability assay |
| 02/19/2004 | WO2002063037A9 Method for identifying functional nucleic acids |
| 02/19/2004 | WO2002061086A3 Human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1 |
| 02/19/2004 | WO2002052039A3 Methods for selecting and producing pharmaceutical compounds using a library responsive to transcription factors |
| 02/19/2004 | WO2002048346A3 Transgenic mice containing bsmap gene disruptions |
| 02/19/2004 | WO2002048337A3 Secreted human proteins |
| 02/19/2004 | WO2002048326A3 Human caplain proteins and polynucleotides coding therefor |
| 02/19/2004 | WO2002046477A3 Endogenous retroviruses up-regulated in prostate cancer |
| 02/19/2004 | WO2002046463A3 Nucleic acid extraction method and kit |
| 02/19/2004 | WO2002046429A3 Polypeptides having glucoamylase activity and nucleic acids encoding same |
| 02/19/2004 | WO2002042328A3 Method for studying the effects of commensal microflora on mammalian intestine and treatments of gastrointestinal-associated disease based thereon |
| 02/19/2004 | WO2002038788A3 Process for the fermentative preparation of l-amino acids using coryneform bacteria |
| 02/19/2004 | WO2002038738A3 Chimeric molecules to modulate gene expression |
| 02/19/2004 | WO2002029111A8 Methods for introducing biomolecules and uses thereof |
| 02/19/2004 | WO2002028888A3 Mimotope of neisseria meningitides lipooligosaccharide and vaccines containing the same |
| 02/19/2004 | WO2002024214A3 Use of glp -2 in combination with another therapeutic agent in bone-related and nutrition-related disorders |
| 02/19/2004 | WO2002012480A3 Yeast alpha-amylase promoter and uses thereof |
| 02/19/2004 | WO2001088190A3 Poly-primed amplification of nucleic acid sequences |
| 02/19/2004 | WO2001040438A3 Methods and compositions for regulating lymphocyte activity |
| 02/19/2004 | WO2000075289A8 Compositions and methods for targeted gene insertion |
| 02/19/2004 | WO2000075277A3 A MOLECULAR MARKER BASED ON THE Frk2 (FRUCTOKINASE 2) GENE |
| 02/19/2004 | US20040034889 Using agrobacterium to transform and propagate disease and herbicide resistant plants |
| 02/19/2004 | US20040034887 Comprises DNA repair enzyme for decreasing free radical damage and increasing crop yield of transgenic plants |
| 02/19/2004 | US20040034886 Comprises nucleotide sequences coding polypeptide which controls tocol concentration in plant seeds; improving antioxidant quality of grain for use as food for humans and animals |
| 02/19/2004 | US20040034885 Methods of using viral replicase polynucleotides and polypeptides |
| 02/19/2004 | US20040034884 Trichothecene-resistant transgenic plants |
| 02/19/2004 | US20040034882 Transgenic rodent with mutation in one allele of the corticotropin releasing factor receptor 2 protein for use as animal model in treating and diagnosing anxiety, depression, obesity and diabetes |
| 02/19/2004 | US20040034881 Comprises rodent containing mutation in programmed cell death-1 receptor (PD-1) gene for use as animal model in diagnosis and treatment of dilated cardiomyopathy |
| 02/19/2004 | US20040034880 Comprises trangenic caenorhabditis elegans mutants associated with constitutive pharyngeal pumping, increased gut permeability and/or altered molecular transport for use as animal model and drug screening tools |
| 02/19/2004 | US20040034879 Mammalian sex selection using genetic modification |
| 02/19/2004 | US20040034878 Using transgenic hypercellular nonhuman organisms as cell proliferating gene therapeutic tools |
| 02/19/2004 | US20040034211 For DNA, using Denaturing Matched Ion Polynucleotide Chromatography; includes analysis of PCR amplification products to identify factors that affect PCR replication fidelity, design of PCR primers, selection of temperature |
| 02/19/2004 | US20040034210 Novel polypeptide-protein p125-77.22 and a polynucleotide encoding the same |
| 02/19/2004 | US20040034199 Human pellino polypeptides |
| 02/19/2004 | US20040034197 Biosynthesizing trypsin and/or trypsinogen amino acid sequences, analogs and catalytic polypeptides with altered active sites and binding domains which recognize and bind to ester leaving groups |
| 02/19/2004 | US20040034195 Multimerized highly functional antifreeze protein |
| 02/19/2004 | US20040034191 Novel peptide-conjugated oligomeric compounds |
| 02/19/2004 | US20040034088 For treating microbial/fungal infections |
| 02/19/2004 | US20040034043 Positively-charged peptide nucleic acid analogs with improved properties |
| 02/19/2004 | US20040033980 Method of down-regulating gene expression |
| 02/19/2004 | US20040033979 Antisense modulation of Fas mediated signaling |
| 02/19/2004 | US20040033978 Antisense oligonucleotides complementary to and that hybridize with RNA, used for gene expression inhibition, prophylaxis and medical diagnosis |
| 02/19/2004 | US20040033977 Oligonucleotide modulation of cell adhesion |
| 02/19/2004 | US20040033976 Antisense modulation of mekk3 expression |
| 02/19/2004 | US20040033975 Whole cell engineering using real-time metabolic flux analysis |
| 02/19/2004 | US20040033952 Modified mature insulin variants and composition containing same |
| 02/19/2004 | US20040033951 Modified mature insulin variants and composition containing same |
| 02/19/2004 | US20040033932 Myc targets |
| 02/19/2004 | US20040033626 Method for gold deposition |
| 02/19/2004 | US20040033608 Plasmids, strains, and methods of use |
| 02/19/2004 | US20040033607 Comprises nucleotide sequences coding vernalization independence polypeptides (VIP) for contolling the time of flowering in agriculure important crop plants such as tomatoes, corn and lettuce |
| 02/19/2004 | US20040033606 Comprises nucleotide sequences coding mitochondrial enzymatic polypeptide for improving fatty acid biosynthesis, glycerolipid storage, seed size and weight, flowering and generation time of plants; antisense therapy |
| 02/19/2004 | US20040033605 Using recombinant adenoviral vectors for the delivery and expression of heterologous nucleic acids in nervous system tissues; gene therapy |
| 02/19/2004 | US20040033604 Plasmid coding viral regulatory sequences for use as genetic transfer tool; gene therapy |
| 02/19/2004 | US20040033603 Biotinylation of proteins |
| 02/19/2004 | US20040033602 Using small interfering RNA (siRNA) sequences and polypeptides containing enzymatic domains to control gene expression in cell systems; antisense agents |
| 02/19/2004 | US20040033601 Gene regulatory networks and methods of interdiction for controlling the differentiation state of a cell |
| 02/19/2004 | US20040033600 Ecdysone receptor-based inducible gene expression system |
| 02/19/2004 | US20040033597 Multipotent neural stemcells from peripheral tissues and uses thereof |
| 02/19/2004 | US20040033596 Inducing site-specific mitotic recombination in the plurality of isolated parent cells from heterozygous cellular library, culturing these cells to produce daughter cells, selecting daughter cells containing homogygous genetic modification |
| 02/19/2004 | US20040033595 Conditionally replicating vectors for inhibiting viral infections |
| 02/19/2004 | US20040033594 Comprises RNA viral sequences for use in development of diagnostics and genetic vaccines against viral infection |
| 02/19/2004 | US20040033586 Pasteurella and/or actinobacillus mutant coding polypeptide for prevention and treatment of infectious disease; veterinary medicine |
| 02/19/2004 | US20040033585 Preparing tobbaco mosaic viral particles comprising therapeutic polypeptides for treatment of infectious diseases and tumors; immunotherapy; genetic vaccines |
| 02/19/2004 | US20040033583 Isomerases |
| 02/19/2004 | US20040033580 Thermopallium culture for fermenting alkaline favorable, heat resistant pullulanase and/or amylase for use in detergent, paper, pulp and textile industry |
| 02/19/2004 | US20040033577 Herbicides test method |
| 02/19/2004 | US20040033572 Polyhydroxyalkanoate biopolymer compositions |
| 02/19/2004 | US20040033570 Transforming the organism (Lovastatin producing organism) with the D4B segment of aspergillus terreus, wherein the segment is transcribed and translated, and wherein an increase in lovastatin production occurs |
| 02/19/2004 | US20040033569 Using site directed mutagenesis to determine and identify physical landscapes associated with protein structure, function and folding |
| 02/19/2004 | US20040033568 Method and reagent for treatment of diseases caused by expression of the c-myc gene |
| 02/19/2004 | US20040033565 Isolated human G-Protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof |
| 02/19/2004 | US20040033564 Method for increasing solubility of target protein using RNA-binding protein as fusion partner |
| 02/19/2004 | US20040033560 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/19/2004 | US20040033559 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/19/2004 | US20040033558 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/19/2004 | US20040033556 Monascus purpureus mutant and its use in preparing yellow pigment |
| 02/19/2004 | US20040033542 Shc protein-related methods and compositions for the prognosis of breast, prostate and ovarian cancer |
| 02/19/2004 | US20040033535 Antibodies to OPGL |
| 02/19/2004 | US20040033531 Kit which utilizes fluorescent polarization to monitor nucleic acid hybridization |
| 02/19/2004 | US20040033527 Methods of using a three-dimensional model of a Fc epsilon receptor alpha chain |
| 02/19/2004 | US20040033526 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 02/19/2004 | US20040033525 Releasable nonvolatile mass-label molecules |
| 02/19/2004 | US20040033523 Coleopteran-resistant transgenic plants and methods of their production |
| 02/19/2004 | US20040033520 Diagnosing metastatic colorectal, stomach and/or esophageal cancer in vitro; immunoassay; radioimaging tumors; immunotherapeutics; genetic vaccines |
| 02/19/2004 | US20040033518 Characterization of single stranded nucleic acids by melting analysis of secondary structure using double strand-specific nucleic acid dye |
| 02/19/2004 | US20040033517 Compositions and methods relating to endothelial cell signaling using the protease activated receptor (PAR1) |
| 02/19/2004 | US20040033516 Diagnosing autoimmune disease via presence or absence of allelic human leukocyte antigen amplification product |
| 02/19/2004 | US20040033515 Preparing a fluidic device for detection of restriction fragment length polymorphism; high throughput macromolecular analysis using diffraction gradient lithography gradient interfaces |
| 02/19/2004 | US20040033511 Site-specific antibody-mediated activation of proapoptotic cytokines: AMAIZEe (antibody-mediated apoptosis inducing cytokines) |